Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer

Stereotactic ablative radiotherapy of 60 Gy in eight fractions is safe for ultracentral non‐small cell lung cancer

Abstract Background There is no consensus on the definition or recommended radiotherapy treatment of ultracentral non‐small cell lung cancer (NSCLC). Here, we report our institution's experience in treating ultracentral lung cancer patients with stereotactic ablative radiotherapy (SABR) of 60 G...

Full description

Bibliographic Details
Main Authors: Dan Yang, Jianing Cui, Jun Zhao, Jing You, Rong Yu, Huiming Yu, Leilei Jiang, Dongming Li, Bo Xu, Anhui Shi
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Thoracic Cancer
Subjects:
Clinical outcomes
dosimetry
SABR
ultracentral NSCLC
Online Access:https://doi.org/10.1111/1759-7714.13335

Internet

https://doi.org/10.1111/1759-7714.13335

Similar Items